Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized multicenter open label phase III factorial trial evaluating the 3 years
OS in patients with locally advanced squamous cell carcinoma of head and neck treated with
locoregional treatment (radiotherapy plus concomitant chemotherapy or cetuximab) with or
without neoadjuvant chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Associazione Volontari Pazienti Oncologici
Collaborator:
Mario Negri Institute for Pharmacological Research